Europe Interventional Cardiology Market Size, Share & COVID19 Impact Analysis by Product (Coronary Atherectomy devices, Catheters (IVUS, OCT, Diagnostic, Balloon, Interventional), Guidewires (Diagnostic, Interventional), Stents, Introducer Sheaths, Vascular Closure, and CEP devices) – Forecast to 2027
- Year: 2020
- Scope: 2016-2026
- Region: Europe
- Pages: 513
- Published Date: 11/30/2020
- Type: MedSuite
In 2020, the European interventional cardiology market size was valued at approximately €928 million, down from nearly €1.2 billion in 2019 due to the impact of COVID-19. The European market size is expected to decrease over the forecast period and reach €1 billion in 2026.
Over 50% of the European interventional cardiology market share was occupied by Boston Scientific, Abbott, and Medtronic. Overall, this market research includes an analysis of 46 interventional cardiology companies spawning across more than 15 countries in Europe.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Interventional Cardiology Procedure Volumes in Europe
- Market Forecasts Until 2026, and Historical Data to 2016
- Market Drivers & Limiters for Each EU Interventional Cardiology Market Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact on the Interventional Cardiology Market in Europe
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
COVID19 Impact on EU Interventional Cardiology Market
Due to COVID19, the European Interventional Cardiology market size declined by almost 27% from 2019, resulting in a valuation of approximately €928 million in 2020. The market size is expected to return to pre-COVID19 levels in 2022.
In March 2020, millions of patients had their care delayed as hospitals canceled non-urgent operations, including some surgeries for people with heart and lung conditions. The purpose of postponing non-essential elective surgeries and medical procedures was to conserve medical resources for COVID-19-related and life-threatening cases. Since this announcement, cardiovascular procedures were severely impacted. While PCI procedures are still considered urgent in treating acute myocardial infarction (MI), or heart attacks, only a small proportion of PCI procedures performed on patients were for these life-threatening conditions. The rest of the PCI procedures are categorized as “elective procedures” and were avoided or deferred during the pandemic.
EU Interventional Cardiology Market Insights
Technologies such as computer tomography (CT), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) are becoming more efficient at diagnosing cardiovascular diseases. These higher-resolution technologies are expected to be better at identifying cardiovascular disease during the first procedure, negating the need for a second procedure and limiting the total number of diagnostic procedures performed. Prices for these image-guided devices are much higher than traditional interventional devices, resulting in upwards pressure on market value.
The growth of image-guided devices for interventional cardiology, such as OCT and IVUS catheters, is heavily dependent on the annual volume of diagnostic and interventional catheterization procedures performed. Both PCI and angiography procedures are expected to exhibit flat growth over the forecast period, outside of COVID-19-related fluctuations. The rising demand for effective diagnostic cardiovascular imaging techniques is one of the factors resulting in greater adoption of IVUS devices.
EU Interventional Cardiology Market Share Insight
In 2020, the European Interventional Cardiology market share was dominated by three companies – Boston Scientific, Abbot, and Medtronic.
Boston Scientific was the leading competitor in the European market for interventional cardiology devices in 2020. The company was the leader of several segments, including coronary stents, balloon catheters, embolic protection devices, and atherectomy devices.
Abbott was the second-leading competitor in the European Interventional cardiology device market. The company led the interventional coronary guidewire, diagnostic coronary catheter and guidewire and coronary OCT catheter markets. Abbot greatly expanded its presence in the European market through its acquisition of St. Jude Medical in 2017.
Olympus was the second-leading competitor in the market in 2020. The company, as the number one manufacturer of endoscopes in the world, used its trusted and established brand name to capture a portion of the video endoscopy market in Europe. Olympus’ position is primarily attributable to its strong share of the surgical camera system market.
RESEARCH REGIONAL COVERAGE
Throughout this research series, iData Research has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The countries covered are:
- Benelux (Belgium, Netherlands, and Luxembourg)
- Scandinavia (Norway, Finland, Sweden, and Denmark)
Detailed Market Segmentation
While this MedSuitereport contains all of the EU Interventional Cardiology Devices market analysis and data, each of the market segments is also available as stand-alone MedCore reports.
- Coronary Stent Market – MedCore – The market is further broken down into segments by:
- Device Type: Bare-Metal Stents, and Drug-Eluting Stents.
- Coronary Balloon Catheter Market – MedCore – The market is also further segmented by
- Device Type: PTCA Balloon, Specialty Balloon, and Drug-Eluting Balloon catheters.
- Coronary Atherectomy Device Market – MedCore – This analysis of the market is further broken down by:
- Device Type: Laser and Mechanical Atherectomy device markets.
- Introducer Sheath Market – MedCore – This market is further broken down by:
- Device Type: Femoral and Radial Introducer Sheaths.
- Coronary Vascular Closure Device (VCD) Market – MedCore – The market analysis is further segmented by:
- Device Type: Femoral and Radial Closure Devices.
- Diagnostic Coronary Catheter & Guidewire Market – MedCore – The analysis is broken down by:
- Device Type: Diagnostic Coronary Catheter, Diagnostic Coronary Guidewire, and Fractional Flow Reserve Guidewire markets.
- Interventional Coronary Catheter Market – MedCore – The interventional catheters are used to place devices, such as stents and balloons, and are analyzed on a unit-basis within this European report.
- Interventional Coronary Guidewire Market – MedCore – Interventional guidewires are often the first device type to cross an arterial lesion, and they are analyzed in-depth within this market research.
- Coronary Embolic Protection Device Market – MedCore – The research includes an in-depth analysis of the Coronary Embolic Protection Device market.
- Coronary Intravascular Ultrasound (IVUS) Market – MedCore – This European market research takes a closer look at the fast-growing Coronary IVUS device market.
- Coronary Optical Coherency Tomography Market – MedCore – In-depth analysis of the Coronary Optical Coherency Tomography market in Europe.
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
TABLE OF CONTENTS FOR EUROPEAN INTERVENTIONAL CARDIOLOGY REPORT SUITETABLE OF CONTENTS ILIST OF FIGURES XIILIST OF CHARTS XXVIIEXECUTIVE SUMMARY 1EUROPE INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW 1COMPETITIVE ANALYSIS 4MARKET TRENDS 7MARKET DEVELOPMENTS 10PROCEDURES INCLUDED 12MARKETS INCLUDED 13VERSION HISTORY 14RESEARCH METHODOLOGY 15Step 1: Project Initiation & Team Selection 15Step 2: Prepare Data Systems and Perform Secondary Research 18Step 3: Preparation for Interviews & Questionnaire Design 20Step 4: Performing Primary Research 21Step 5: Research Analysis: Establishing Baseline Estimates 23Step 6: Market Forecast and Analysis 24Step 7: Identify Strategic Opportunities 26Step 8: Final Review and Market Release 27Step 9: Customer Feedback and Market Monitoring 28
IMPACT OF COVID-19 ON THE EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKET2.1 INTRODUCTION 292.1.1 Treatable Population and the COVID-19 Virus 302.1.2 Market Specifics 302.2 COUNTRY PROFILES 322.3 ANALYSIS BY MARKET SEGMENT 332.3.1 Best Case Scenario 332.3.2 Base Case Scenario 372.3.3 Worst Case Scenario 41
DISEASE OVERVIEW3.1 BASIC ANATOMY 463.2 DISEASE TREATMENTS AND DIAGNOSTICS 483.2.1 General Diagnostics 483.2.2 Coronary Artery Disease (CAD) 483.2.3 Myocardial Infarction (MI) 493.2.4 Angina Pectoris 503.3 PATIENT DEMOGRAPHICS 513.3.1 General Statistics 51
PRODUCT ASSESSMENT4.1 INTRODUCTION 534.2 PRODUCT PORTFOLIOS 534.2.1 Coronary Stent Market 534.2.2 Coronary Balloon Catheter Market 564.2.3 Balloon-Inflation Device Market 594.2.4 Interventional Coronary Catheter Market 604.2.5 Interventional Coronary Guidewire Market 634.2.6 Coronary Embolic Protection Device Market 6188.8.131.52 Saphenous Vein Grafts 6184.108.40.206 Protection Mechanism 6220.127.116.11.1 Filter Basket 618.104.22.168.2 Distal Balloon Occlusion 674.2.7 Coronary Atherectomy Device Market 622.214.171.124 Laser Atherectomy 6126.96.36.199 Directional Coronary Atherectomy (DCA) 6188.8.131.52 Mechanical Atherectomy 694.2.8 Coronary Thrombectomy Device Market 704.2.9 Coronary Chronic Total Occlusion Device Market 714.2.10 Coronary Introducer Sheath Market 7184.108.40.206 Femoral Approach 7220.127.116.11 Radial/Brachial Approach 744.2.11 Coronary Vascular Closure Device Market 764.2.12 Diagnostic Coronary Catheter & Guidewire 784.2.13 Coronary Intravascular Ultrasound Market 804.2.14 Optical Coherence Tomography Market 824.2.15 Hemostasis Valve Market 844.3 REGULATORY ISSUES AND RECALLS 854.3.1 Abbott 818.104.22.168 Coronary Stent 822.214.171.124 Coronary Balloon Catheter 8126.96.36.199 Introducer Sheath 8188.8.131.52 Coronary Vascular Closure Device 874.3.2 Boston Scientific 8184.108.40.206 Coronary Stent 8220.127.116.11 Coronary Balloon Catheter 818.104.22.168 Balloon-Inflation Device 822.214.171.124 Interventional Coronary Catheter 8126.96.36.199 Interventional Coronary Guidewire 904.3.2.6 Coronary Thrombectomy 914.3.3 Cardinal Health 9188.8.131.52 Coronary Stent 924.3.4 Medtronic 9184.108.40.206 Coronary Stent 9220.127.116.11 Introducer Sheath 918.104.22.168 Coronary Balloon Catheter 922.214.171.124 Interventional Coronary Catheter 944.3.5 Merit Medical Systems 9126.96.36.199 Introducer Sheath 964.3.7 Terumo 9188.8.131.52 Interventional Coronary Catheter 9184.108.40.206 Introducer Sheath 9220.127.116.11 Coronary Vascular Closure Device 994.4 CLINICAL TRIALS 1004.4.1 Coronary Stent 1014.4.1.1 Abbott 1014.4.1.2 Boston Scientific 1024.4.1.3 Medtronic 1034.4.2 Coronary Balloon Catheter 1074.4.2.1 Boston Scientific 1074.4.2.2 Medtronic 1074.4.3 Balloon Inflation Device 1084.4.3.1 Central Arkansas Veterans Healthcare System 1084.4.3.2 Guy’s and St Thomas’ NHS Foundation Trust 1084.4.4 Interventional Coronary Catheter 1094.4.4.1 Medtronic 1094.4.4.2 Philips 1114.4.5 Coronary Embolic Protection Device 118.104.22.168 Icahan School of Medicine at Mount Sinai 122.214.171.124 Javelin Medical 1126.96.36.199 Keystone Heart 1188.8.131.52 Microvention-Terumo, Inc 1134.4.6 Coronary Atherectomy Device 1184.108.40.206 Segeberger Kliniken GmbH 1220.127.116.11 Spectranetics Corporation 1144.4.7 Coronary Vascular Closure Device 118.104.22.168 Cordis Corporation 122.214.171.124 Medtronic 1126.96.36.199 Terumo Medical Corporation 1164.4.8 Coronary Intravascular Ultrasound 1188.8.131.52 Aarhhus University Hospital Skejby 1184.108.40.206 European Cardiovascular Research Institute 1174.4.9 Coronary Optical Coherence Tomography 1220.127.116.11 Columbia University 118
EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW5.1 INTRODUCTION 1195.2 CURRENCY EXCHANGE RATE 1215.3 MARKET OVERVIEW 1225.4 TREND ANALYSIS BY SEGMENT 1305.5 DRIVERS AND LIMITERS 1345.5.1 Market Drivers 1345.5.2 Market Limiters 1355.6 COMPETITIVE MARKET SHARE ANALYSIS 1385.7 MERGERS AND ACQUISITIONS 1455.8 COMPANY PROFILES 1475.8.1 Abbott 1475.8.2 Asahi Intecc 1495.8.3 Boston Scientific 1505.8.4 Cardinal Health 1518.104.22.168 Cordis (Cardinal Health) 1525.8.5 Cardiovascular Systems Inc. 1535.8.6 Cook Medical 1545.8.7 Medtronic 1555.8.8 Merit Medical Systems 1575.8.9 Penumbra 1585.8.10 Philips 1595.8.11 Teleflex 1615.8.12 Terumo 1635.9 SWOT ANALYSIS 1655.9.1 Abbott 1665.9.2 Asahi Intecc 1675.9.3 Boston Scientific 1685.9.4 Cardinal Health 1695.9.5 Cardiovascular Systems Inc. 1705.9.6 Cook Medical 1715.9.7 Medtronic 1725.9.8 Merit Medical Systems 1735.9.9 Penumbra 1745.9.10 Philips 1755.9.11 Teleflex 1765.9.12 Terumo 177
COUNTRY PROFILES6.1 INTRODUCTION 1786.1.1 Population 1786.1.2 GDP Per Capita 1786.1.3 Price Index 1786.2 GERMANY 1796.3 FRANCE 1806.4 UNITED KINGDOM 1816.5 ITALY 1826.6 SPAIN 1836.7 BENELUX 1846.8 SCANDINAVIA 1856.9 AUSTRIA 1866.10 SWITZERLAND 1876.11 PORTUGAL 188
PROCEDURE NUMBERS7.1 PROCEDURES 1897.1.1 Angiography Procedures 1922.214.171.124 Angiography Procedures by Approach 1957.1.2 Angioplasty/PCI Procedures 19126.96.36.199 Angioplasty/PCI Procedures by Approach 1997.1.3 SVG Procedures 2007.1.4 FFR Procedures 2037.1.5 IVUS Procedures 2067.1.6 OCT Procedures 2097.1.7 Catheterization Procedures 212
CORONARY STENT MARKET8.1 INTRODUCTION 2158.2 MARKET OVERVIEW 2178.3 MARKET ANALYSIS AND FORECAST 2228.3.1 Total Coronary Stent Market 2228.3.2 Drug-Eluting Stent Market 2298.3.3 Bare-Metal Stent Market 2378.4 DRIVERS AND LIMITERS 2448.4.1 Market Drivers 2448.4.2 Market Limiters 2448.5 COMPETITIVE MARKET SHARE ANALYSIS 247
CORONARY BALLOON CATHETER MARKET9.1 INTRODUCTION 2529.2 MARKET OVERVIEW 2549.3 MARKET ANALYSIS AND FORECAST 2599.3.1 Total Coronary Balloon Catheter Market 2599.3.2 PTCA Balloon Catheter Market 2669.3.3 Drug-Eluting Balloon Market 2739.3.4 Specialty Balloon Catheter Market 2809.4 DRIVERS AND LIMITERS 2879.4.1 Market Drivers 2879.4.2 Market Limiters 2879.5 COMPETITIVE MARKET SHARE ANALYSIS 290
INTERVENTIONAL CORONARY CATHETER MARKET10.1 INTRODUCTION 29410.2 MARKET ANALYSIS AND FORECAST 29510.3 DRIVERS AND LIMITERS 30210.3.1 Market Drivers 30210.3.2 Market Limiters 30210.4 COMPETITIVE MARKET SHARE ANALYSIS 305
INTERVENTIONAL CORONARY GUIDEWIRE MARKET11.1 INTRODUCTION 30911.2 MARKET ANALYSIS AND FORECAST 31011.3 DRIVERS AND LIMITERS 31711.3.1 Market Drivers 31711.3.2 Market Limiters 31811.4 COMPETITIVE MARKET SHARE ANALYSIS 320
CORONARY EMBOLIC PROTECTION DEVICE MARKET12.1 INTRODUCTION 32512.1.1 Saphenous Vein Grafts 32512.1.2 Protection Mechanism 32612.2 MARKET ANALYSIS AND FORECAST 32712.3 DRIVERS AND LIMITERS 33412.3.1 Market Drivers 33412.3.2 Market Limiters 33512.4 COMPETITIVE MARKET SHARE ANALYSIS 337
CORONARY ATHERECTOMY DEVICE MARKET13.1 INTRODUCTION 34013.2 MARKET OVERVIEW 34113.3 MARKET ANALYSIS AND FORECAST 34613.3.1 Total Coronary Atherectomy Device Market 34613.3.2 Mechanical Atherectomy Device Market 35313.3.3 Laser Atherectomy Device Market 36013.4 DRIVERS AND LIMITERS 36713.4.1 Market Drivers 36713.4.2 Market Limiters 36813.5 COMPETITIVE MARKET SHARE ANALYSIS 370For a Full Table of Contents, please contact iData.
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.